RED ESPAÑOLA DE ESCLEROSIS MULTIPLE

Meeting Abstract. 2021

Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

Vegas-Revenga, N; (...); Blanco, R

Article. 10.1016/j.ajo.2018.12.019. 2019

Anti-lipid oligoclonal IgM bands contribute to progressive multifocal leukoencephalopathy (PML) risk stratification in multiple sclerosis patients treated with natalizumab

Villar, L.; (...); Alvarez-Cermeno, J. C.

Article. 2013

Antireconverin antibodies in ocular chronic graft versus host disease: A new cause of nonparaneoplasic autoimmune retinopathy

Aguilar Gonzalez, Marina; (...); Espana Gregori, Enrique

Article. 10.1177/11206721221123779. 2022

Anti-TNF-alpha therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients

Calvo-Río V; (...); González-Gay MA

Article. 10.1093/rheumatology/keu266. 2014

Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease.

Prats-Climent, Joan; (...); Marti-Bonmati, Luis

Article. 10.1007/s10916-022-01836-w. 2022

Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer's Disease and Frontotemporal Dementia.

Álvarez-Sánchez L; (...); Cháfer-Pericás C

Article. 10.3390/ijms24021226. 2023

Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice

Espiño M; (...); Villar LM

Article. 10.1016/j.cca.2014.08.004. 2015

Association between Tomographic Characteristics of Pterygium and Preoperative Anterior and Posterior Topography Measured by Anterior Segment Optical Coherence Tomography

Aguilar-Gonzalez, Marina; (...); Peris-Martinez, Cristina

Article. 10.3390/life14101245. 2024

Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis.

Lunemann JD; (...); Comabella M

Article. 10.1212/NXI.0000000000200270. 2024

Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.

Monreal, Enric; (...); Villar LM

Article. 10.1001/jamaneurol.2023.0010. 2023

Atypical periodic alternating nystagmus responding to high-dose intravenous immunoglobulins: a case report

Argente-Escrig, H; (...); Casanova Estruch B

Article. 10.1186/s12974-017-0846-1. 2017

Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Burman, J; (...); Farge, D

Article. 10.1038/bmt.2017.40. 2017

Autologous hematopoietic stem cell transplantation in multiple sclerosis: updating outcomes in the Valencian cohort.

Boix Lago, A.; (...); Casanova Estruch, B.

Meeting Abstract. 2023

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis

Casanova, B; (...); Coret, F

Article. 10.1007/s10072-017-2933-6. 2017

Automated Glioblastoma Segmentation Based on a Multiparametric Structured Unsupervised Classification

Juan-Albarracín J; (...); García-Gómez JM

Article. 10.1371/journal.pone.0125143. 2015

Automatic etiological classification of stroke thrombus digital photographs using a deep learning model

Lucero-Garofano, Alvaro; (...); Manjon, Jose V.

Article. 10.3389/fneur.2025.1534845. 2025

Basal levels of serum neurofilament light in normal aging and multiple sclerosis patients

Gasque Rubio, R.; (...); Casanova Estruch, B.

Meeting Abstract. 2021

Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis Patients

Mathur, D; (...); Lopez-Rodas, G

Article. 10.3389/fncel.2017.00209. 2017

Biomarkers in multiple sclerosis: an update for 2014

Fernandez O; (...); Montalban X

Review. 10.33588/rn.5812.2014247. 2014

Brain atrophy in relapsing optic neuritis is associated to anti-mog antibodies

Navarro Canto, L.; (...); Casanova Estruch, B.

Meeting Abstract. 2019

Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype

Canto, LN; (...); Estruch, BC

Article. 10.3389/fneur.2019.01157. 2019

Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis.

Perez-Miralles, Francisco Carlos; (...); Casanova, Bonaventura

Article. 10.1002/brb3.2044. 2021

Bypassing hazard of housekeeping genes: their evaluation in rat granule neurons treated with cerebrospinal fluid of multiple sclerosis subjects

Mathur D; (...); Burgal-Marti M

Article. 10.3389/fncel.2015.00375. 2015

Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series.

Quintanilla-Bordás C; (...); Casanova B

Article. 10.3389/fneur.2022.897275. 2022

Cerebrospinal fluid kappa free light chains and IgM index for diagnosis and prognosis in multiple sclerosis

Gil-Perotin, S.; (...); Casanova, B.

Meeting Abstract. 2021

Cervical spinal cord T2 lesions independently predict early conversion to secondary progressive multiple sclerosis: a longitudinal 10-year study

Lacruz-Ballester, L.; (...); Casanova-Estruch, B.

Meeting Abstract. 2021

Circulating mirna signatures in PPMS

Martin, MMS; (...); Torrenta, LRI

Meeting Abstract. 2020

Clinical and neuroimaging characterization of two C9orf72-positive siblings with amyotrophic lateral sclerosis and schizophrenia

Vázquez-Costa JF; (...); Sevilla T

Article. 10.3109/21678421.2015.1112407. 2016

Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study

Oreja-Guevara, Celia; (...); Rio, Jordi

Article. 10.1016/j.msard.2024.105787. 2024

Clinical evaluation of rituximab treatment for neuromyelitis optica

Fernández-Megía MJ; (...); Poveda-Andrés JL

Article. 10.1016/j.nrl.2014.09.001. 2015

Clinical experience with rituximab in the treatment of refractory multiple sclerosis

Gascon, F.; (...); Coret, F.

Meeting Abstract. 2014

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis

Lorente Fernández L; (...); Casanova-Estruch B

Article. 10.1016/j.nrl.2013.06.014. 2014

Clinical impact of early brain atrophy in clinically isolated syndromes.

Pérez-Miralles F; (...); Montalban X

Article. 10.1177/1352458513488231. 2013

Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels

Quintanilla-Bordas, Carlos; (...); Casanova, Bonaventura

Article. 10.3389/fneur.2024.1477335. 2024

Clinical, demographic and laboratory data associated with PML risk in patients treated with natalizumab

Toboso, I; (...); Villar, LM

Meeting Abstract. 2017

Cognitive impairment in multiple sclerosis: diagnosis and monitoring.

Meca-Lallana, Virginia; (...); Perez-Miralles, Francisco

Article. 10.1007/s10072-021-05165-7. 2021

Cognitive performance and health-related quality of life in patients with neuromyelitis optica spectrum disorder

Lopez-Soley, Elisabet; (...); Solana, Elisabeth

Meeting Abstract. 2022

Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder.

Lopez-Soley E; (...); Solana E

Article. 10.3390/jpm12050743. 2022

Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis.

Gil-Perotin S; (...); Casanova B

Article. 10.3389/fneur.2019.01008. 2019

Comorbilidad en esclerosis multiple y su abordaje asistencial.

Estruch BC

Abstract of Published Item. 10.1016/S0025-7753(15)30004-X. 2014

Comparative Assessment of Simoa and Lumipulse for Measuring Serum Neurofilament Light Chain in Multiple Sclerosis Patients

Gasque-Rubio, Raquel; (...); Perez-Miralles, Francisco

Article. 10.1155/2024/1950913. 2024

COMPARATIVE STUDY OF ADALIMUMAB, INFLIXIMAB AND CERTOLIZUMAB IN THE TREATMENT OF CYSTOID MACULAR EDEMA DUE TO BEHCET'S DISEASE

Martin-Varillas, J. L.; (...); Blanco, R.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4397. 2023

COMPARATIVE STUDY OF INFLIXIMAB VERSUS ADALIMUMAB IN REFRACTORY UVEITIS ASSOCIATED TO CYSTOID MACULAR OEDEMADUE TO BEHCET'S DISEASE. MULCITENTER STUDY OF 40 CASES

Atienza-Mateo, B; (...); Blanco, R

Meeting Abstract. 10.1136/annrheumdis-2018-eular.3891. 2018

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis Due to Behcet's Disease. National Multicenter Study of 177 Cases

Atienza-Mateo, B; (...); Blanco, R

Meeting Abstract. 2018

Comparative study of infliximab versus adalimumab in refractory uveitis due to Behet's disease, National multicenter study of 177 cases.

Atienza-Mateo B; (...); Blanco R

Article. 10.1002/art.41026. 2019

COMPARATIVE STUDY OF THE TREATMENT OF REFRACTORY CYSTOID MACULAR OEDEMA TO CONVENTIONAL IMMUNOSUPPRESSIVE THERAPY: TOCILIZUMAB VS ANTI-TNF. MULTICENTER STUDY OF 59 PATIENTS

Martin-Varillas, JL; (...); Blanco, R

Meeting Abstract. 10.1136/annrheumdis-2018-eular.3999. 2018

Complications Associated with Mohs Micrographic Surgery: Data from the Nationwide Prospective Cohort REGESMOHS

Ruiz-Salas, Veronica; (...); Garcia-Doval, Ignacio

Article. 10.1159/000517010. 2021

Consensus document on spasticity in patients with multiple sclerosis

Oreja-Guevara, Celia; (...); Fernandez, Oscar

Article. 10.33588/rn.5708.2013374. 2013

Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.

Medina-Polo J; (...); López-Fando L

Article. 10.1002/nau.24276. 2020

Consensus guidelines for the timely detection and diagnosis of disease progression in multiple sclerosis patients

Oreja-Guevara, C; (...); Meca-Lallana, J

Meeting Abstract. 2020

Consensus on early detection of disease progression in patients with multiple sclerosis

Meca-Lallana, Jose E.; (...); Oreja-Guevara, Celia

Article. 10.3389/fneur.2022.931014. 2022

Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients A Delphi Consensus Statement

Massey, Paul R.; (...); Jambusaria-Pahlajani, Anokhi

Article. 10.1001/jamadermatol.2021.3180. 2021

Corneal Biomechanical Parameters With Corneoscleral Contact Lenses in Post-Laser In Situ Keratomileusis Eyes

Montalt, JC; (...); Peris-Martinez, C

Article. 10.1097/ICL.0000000000000420. 2018

Corneal Biomechanics, Retinal Nerve Fiber Layer, and Optic Disc in Children

Bueno-Gimeno, I; (...); Espana-Gregori, E

Article. 10.1097/OPX.0000000000000406. 2014

Corneo-scleral contact lens in a piggyback system for keratoconus: A case report

Porcar, Esteban; (...); Peris-Martinez, Cristina

Article. 10.1016/j.clae.2016.12.007. 2017

Corneoscleral contact lenses fitting on irregular corneas after laser-assisted in situ keratomileusis

Montalt, JC; (...); Peris-Martinez, C

Article. 10.5935/0004-2749.20180061. 2018

Corneoscleral contact lenses for visual rehabilitation after keratoplasty surgery.

Montalt JC; (...); Peris-Martínez C

Article. 10.1016/j.clae.2020.04.009. 2020

Corneo-scleral contact lenses in an uncommon case of keratoconus with high hyperopia and astigmatism

Porcar, E; (...); Peris-Martinez, C

Article. 10.1016/j.clae.2017.07.004. 2017

Corrigendum to "Plasmatic Membrane Expression of Adhesion Molecules in Human Cardiac Progenitor/Stem Cells Might Explain Their Superior Cell Engraftment after Cell Transplantation".

Ontoria-Oviedo I; (...); Sepúlveda P

Correction. 10.1155/2022/9786160. 2022

Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA A receptor encephalitis.

Brändle SM; (...); Dornmair K

Article. 10.1073/pnas.1916337118. 2021

CSF chitinase 3-like-1 association with disability of primary progressive MS

Article. 10.1212/NXI.0000000000000815. 2020

Cytokines profile in the cerebrospinal fluid in chronic relapsing inflammatory demyelinating diseases of the central nervous system

Simo-Castello, M.; (...); Coret, F.

Meeting Abstract. 2014

Changes in Brain Volume in Specific Regions could be related to Disability Progression in Primary Progressive Multiple Sclerosis Patients

Miralles, FP; (...); Casanova, B

Meeting Abstract. 2019

Changes in brain volume in specific regions could predict worsening cognition in primary progressive multiple sclerosis

Meeting Abstract. 2019

Characterization of individual IgM oligoclonal band antibodies from the cerebrospinal fluid (CSF) of multiple sclerosis patients to identify their antigens

Beltran, E.; (...); Dornmair, K.

Article. 2013

Characterization of the gait in patients with relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis measured by FeetMe (R) integrated sensor insole system: Results of the interim analysis

Izquierdo Ayuso, G.; (...); Casanova Estruch, B.

Meeting Abstract. 2021

Chitinase-3-like protein 1 could be a predictor of disability progression in patients with primary progressive multiple sclerosis

Meeting Abstract. 2018

Chitinase-3-like protein 1 could be a predictor of disability progression in patients with primary progressive multiple sclerosis: A one-year follow-up

Meeting Abstract. 2019

Chronic hyperammonemia induces peripheral inflammation that leads to cognitive impairment in rats: reversal by anti-tnfa treatment.

Balzano T; (...); Felipo V

Article. 10.1016/j.jhep.2019.01.008. 2020

Daclizumab in multiple sclerosis.

Perez-Miralles, FC

Review. 10.33588/rn.6608.2018083. 2018

Deciphering Multiple Sclerosis Progression.

Meca-Lallana, Virginia; (...); Perez-Miralles, Francisco Carlos

Review. 10.3389/fneur.2021.608491. 2021

DeepCERES: A deep learning method for cerebellar lobule segmentation using ultra-high resolution multimodal MRI.

Morell-Ortega, Sergio; (...); Manjon, Jose V

Article. 10.1016/j.neuroimage.2025.121063. 2025

Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade

Ribes García S; (...); Casanova Estruch B

Article. 10.1159/000446580. 2016

Design and implementation of a custom targeted next-generation sequencing panel in a series of primary melanomas

De Unamuno, B; (...); Botella, R

Meeting Abstract. 2017

Design and Validation of an Expanded Disability Status Scale Model in Multiple Sclerosis.

Barreiro-Gonzalez, Antonio; (...); Casanova, Bonaventura

Article. 10.1159/000519772. 2022

Development and validation of a model to predict complex Mohs Micrographic Surgery in clinical practice: REGESMOSH scale.

Montero-Vilchez, Trinidad R.; (...); Sanmartin-Jimenez, Onofre

Article. 10.1111/jdv.19056. 2023

Diabetes does not affect outcome of symptomatic carotid stenosis treated with endovascular techniques.

Lago A; (...); Vázquez-Añón V

Article. 10.1159/000346000. 2013

Difference in Regional Brain Volume between Fibromyalgia Patients and Long-Term Meditators

Fayed, Nicolas; (...); Garcia-Campayo, Javier

Article. 2017

Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients

Casanova, B; (...); Coret, F

Article. 10.1007/s10072-018-3442-y. 2018

Diffuse dermal angiomatosis of the breast: clinical and histopathological features

Sanz-Motilva V; (...); Vanaclocha F

Article. 10.1111/j.1365-4632.2012.05812.x. 2014

DISCOVER STUDY, FIRST ANALYSIS SPECIFIC FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS BURDEN AND COST IN SPAIN: INTERIM ANALYSIS RESULTS

Oreja-Guevara, C; (...); Meca-Lallana, J

Meeting Abstract. 2020

Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology.

Brieva, Luis; (...); Moral, Ester

Article. 10.1016/j.msard.2022.103805. 2022

Distal Access Catheter Improves Balloon Guide and Stent Retriever Thrombectomy Outcomes in Nonagenarians.

Puig, Josep; (...); Blasco, Jordi

Article. 10.1111/jon.70012. 2025

Disturbed Glucose Metabolism in Rat Neurons Exposed to Cerebrospinal Fluid Obtained from Multiple Sclerosis Subjects

Mathur, D; (...); Burgal-Marti, M

Article. 10.3390/brainsci8010001. 2018

Documento de consenso sobre la espasticidad en pacientes con esclerosis multiple.

Oreja-Guevara C; (...); Fernández Ó

Abstract of Published Item. 10.33588/rn.5708.2013374. 2013

Does benign multiple sclerosis exist?

Verdini Martinez, Laura; (...); Casanova, Bonaventura

Meeting Abstract. 2023

Does hyaluronidase injected in periocular area change skin ultrastructure?: Standardized in vitro analysis

Aguilar-González M; (...); Pérez-López M

Article. 10.1111/jocd.15014. 2022

Drug load and memory during intracarotid amobarbital procedure in epilepsy

Lozano-García A; (...); Villanueva V

Editorial Material. 10.1111/ane.13491. 2021

Dynamic 18F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study

Quintanilla Bordas, Carlos; (...); Casanova, Bonaventura

Meeting Abstract. 2023

Dynamic contrast-enhanced case-control analysis in 3T MRI of prostate cancer can help to characterize tumor aggressiveness

Sanz-Requena, R; (...); Garcia-Marti, G

Article. 10.1016/j.ejrad.2016.09.022. 2016

Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.

Barreiro-González A; (...); Casanova B

Article. 10.1007/s13760-020-01516-x. 2020

Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers

Alvarez-Sanchez, Lourdes; (...); Chafer-Pericas, Consuelo

Article. 10.3390/ijms241814151. 2023

Early beginning of alemtuzumab: Changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study.

Meca-Lallana, J E; (...); Calles Hernandez, C

Article. 10.1016/j.nrleng.2021.06.006. 2023

Early beginning of alemtuzumab: changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study

Meca-Lallana, J. E.; (...); Hernandez, C. Calles

Article. 10.1016/j.nrl.2021.06.007. 2024

Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases

Megias-Vericat, JE; (...); Poveda, JL

Review. 10.1007/s10072-017-2833-9. 2017

Economic impact and clinical profile of the secondary progressive multiple sclerosis (SPMS) patient: the DISCOVER study

Oreja-Guevara, C.; (...); Meca-Lallana, J. E.

Meeting Abstract. 2021

Economic impact of the secondary progressive multiple sclerosis in spain: interim analysis of the discover study

Oreja-Guevara, C; (...); Meca-Lallana, J

Meeting Abstract. 2020

Eculizumab for a catastrophic relapse in NMOSD: case report.

Gorriz, David; (...); Casanova, Bonaventura

Article. 10.1007/s10072-023-06971-x. 2023

Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.

Meca-Lallana JE; (...); Llarena C

Article. 10.1007/s40120-023-00557-7. 2023

Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.

Alcala, Carmen; (...); Casanova, Bonaventura

Article. 10.1007/s00415-022-10989-0. 2022

Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice.

Letter. 10.1111/ajd.14151. 2023

Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.

Villoslada P; (...); NeuroAdvan study

Article. 10.1212/NXI.0000000000000147. 2015

Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study

Alcala, C; (...); Casanova, B

Article. 10.1007/s00415-018-8899-3. 2018

Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial

Perez-Moreiras, JV; (...); Tocilizumab Graves Orbitopathy Stu

Article. 10.1016/j.ajo.2018.07.038. 2018

Elevation of Chi3l1 in acute disseminated encephalomyelitis: implications in pathogenesis

Gil-Perotin, S; (...); Casanova-Estruch, B

Meeting Abstract. 2018

Elevation of serum neurofilament light-chain levels disclose possible occult progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient receiving ozanimod: a case report.

Quintanilla-Bordás C; (...); Pérez-Miralles FC

Case Reports. 10.3389/fimmu.2024.1465678. 2024

Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABA(A) receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies

Petit-Pedrol M; (...); Dalmau J

Article. 10.1016/S1474-4422(13)70299-0. 2014

Enhancing the First-Pass Effect in Acute Stroke: The Impact of Stent Retriever Characteristics

Murias, Eduardo; (...); Vega, Pedro

Article. 10.3390/jcm13113123. 2024

Eosinophilic follicular reaction induced by Demodex folliculorum mite: a different disease from eosinophilic folliculitis

Sabater-Marco V, Escutia-Muñoz B, Botella-Estrada R

Article. 10.1111/ced.12566. 2015

Erythemato-violaceous plaques on the shin of a trasplanted lung host.

Sahuquillo-Torralba A; (...); Botella-Estrada R

Article. 10.1016/j.medcli.2017.05.024. 2017

Escalation vs. Early Intense Therapy in Multiple Sclerosis.

Casanova, Bonaventura, Quintanilla-Bordas, Carlos, Gascon, Francisco

Article. 10.3390/jpm12010119. 2022

Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?

Tortosa-Carreres J; (...); Pérez-Miralles FC

Article. 10.1016/j.jneuroim.2024.578428. 2024

Executive dysfunction and cortical variations among intimate partner violence perpetrators and the association with sexism.

Romero-Martinez, Angel; (...); Moya-Albiol, Luis

Article. 10.1093/scan/nsae046. 2024

Findings and Utility of Chest Computed Tomography in Pediatric Tuberculosis

Moreno-Ballester, V; (...); Gomez-Pajares, F

Article. 10.1055/s-0037-1604418. 2018

Fingolimod plus steroids prevents return to clinical activity after natalizumab withdrawal

Article. 2013

Fitting Scleral Lenses Less Than 15 mm in Diameter: A Review of the Literature.

Porcar E; (...); Peris-Martínez C

Review. 10.1097/ICL.0000000000000647. 2020

Folliculitis Decalvans Caused by Bacterial Superinfection Secondary to Erlotinib.

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Letter. 10.1016/j.ad.2017.02.032. 2018

Geographic atrophy: Etiopathogenesis and current therapies.

Sastre-Ibanez M; (...); Garcia-Armendariz B

Article. 10.1016/j.oftal.2017.07.004. 2018

Gray matter volume differences in intimate partner violence perpetrators and its role in explaining dropout and recidivism

Romero-Martinez, Angel; (...); Moya-Albiol, Luis

Article. 10.1016/j.jpsychires.2024.09.019. 2024

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

Lopez-Isac, E; (...); ASIG

Article. 10.1038/s41467-019-12760-y. 2019

High Dose Intravenous Methylprednisolone Induces Rapid Improvement in Severe Non-Infectious Uveitis. a Multicenter Study of 120 Patients

Vegas-Revenga, N; (...); Blanco, R

Meeting Abstract. 2018

High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.

Castillo-Villalba, Jessica; (...); Casanova, Bonaventura

Article. 10.3389/fimmu.2022.827738. 2022

Identification of c.104T>G, p.Met35Arg (NM_00314.8) variant in heterozygosity in exon 2 of the PTEN gene as the Causative Factor for Cowden Syndrome: A Medical Case Study.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1093/ced/llad344. 2023

IgG4-related dacryocystitis and aortitis: A new association.

España-Gregori E; (...); Aguilar-González M

Editorial Material. 10.1177/1120672118823123. 2020

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial

Zubizarreta, I; (...); Villoslada, P

Article. 10.1073/pnas.1820039116. 2019

Immune tolerance in patients with Multiple Sclerosis and Neuromyelitis Optica by peptide-loaded tolerogenic dendritic cells: final results of the phase 1b clinical trial and extension

Zubizarreta, I; (...); Villoslada, P

Meeting Abstract. 2019

Immunoglobulin M Oligoclonal Bands: Biomarker of Targetable Inflammation in Primary Progressive Multiple Sclerosis

Villar LM; (...); Bar-Or A

Article. 10.1002/ana.24190. 2014

Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis

Edo Solsona MD; (...); Poveda Andrés JL

Article. 10.2147/PPA.S127508. 2017

IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART (R) IN PATIENTS WITH MULTIPLE SCLEROSIS

Edo-Solsona, M.; (...); Poveda-Andres, J.

Meeting Abstract. 10.1016/j.jval.2016.09.512. 2016

Impact of Corneoscleral Contact Lens Usage on Corneal Biomechanical Parameters in Keratoconic Eyes.

Porcar E; (...); Peris-Martínez C

Article. 10.1097/ICL.0000000000000579. 2019

Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients' Perspective: An Observational Cross-Sectional Study

Meca-Lallana, Jose E.; (...); Maurino, Jorge

Article. 10.1007/s40120-022-00356-6. 2022

Impact of neuromyelitis optica spectrum disorder on quality of life: Assessing the patients' perspective

Meca-Lallana, Jose; (...); Maurino, Jorge

Meeting Abstract. 10.1016/j.jns.2021.118844. 2021

Impact of stigma in patients with primary progressive multiple sclerosis: a one-year follow-up

Mansilla-Polo M, Escutia-Muñoz B, Botella-Estrada R

Meeting Abstract. 2019

Improvements in Quality of Life of Patients with Multiple Sclerosis receiving Alemtuzumab in Clinical Practice: LEMVIDA study

Meca Lallana, Jose; (...); Forner, Mireia

Meeting Abstract. 10.1212/WNL.0000000000202381. 2023

Improvements in quality of life of patients with multiple sclerosis receiving alemtuzumab in clinical practice: the LEMVIDA study.

Meca-Lallana, Jose Eustasio; (...); Toledo, Baldo

Article. 10.1186/s41687-024-00822-9. 2024

Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithm.

Tortosa-Carreres J; (...); Pérez-Miralles FC

Article. 10.1016/j.msard.2023.104997. 2023

Improving the estimation of prognosis for glioblastoma patients by MR based hemodynamic tissue signatures

Fuster-Garcia, E; (...); Garcia-Gomez, JM

Article. 10.1002/nbm.4006. 2018

In Situ RT-PCR Optimized For Electron Microscopy Allows Description Of Subcellular Morphology Of Target mRNA-Expressing Cells In the Brain

LAURA CUBAS NÚÑEZ; (...); Gil-Perotin S

Article. 2017

In situ RT-PCR Optimized for Electron Microscopy Allows Description of Subcellular Morphology of Target mRNA-Expressing Cells in the Brain

Cubas-Nunez, L; (...); Gil-Perotin, S

Article. 10.3389/fncel.2017.00141. 2017

Incomplete Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery).

Oro-Ayude, M.; (...); REGESMOHS (Registro Español de Cirugía de Mohs)

Letter. 10.1111/jdv.17597. 2022

Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis

Comabella, Manuel; (...); Luenemann, Jan D.

Article. 10.1007/s00415-024-12763-w. 2025

Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema.

Udaondo Mirete P; (...); Espana-Gregori, Enrique

Article. 10.3390/jcm12010348. 2023

Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation

Beltrán E; (...); Dornmair K

Article. 10.1093/brain/awu205. 2014

Is it cost-effective to request IgM oligoclonal bands against lipids in daily practice as a biomarker for poor prognosis in multiple sclerosis?

Ribes Garcia, Sara; (...); Bonaventura, Casanova Estruch

Article. 10.1016/j.msard.2023.105033. 2023

La elastografia mediante tecnica Acoustic radiation force impulse es eficaz en la deteccion de fibrosis hepatica en el nino.

Aliaga, SDP; (...); Marti-Bonmati, L

Article. 10.1016/j.rx.2014.04.005. 2015

Late clinical and radiological complications of stereotactical radiosurgery of arteriovenous malformations of the brain.

Parkhutik V; (...); Vazquez V

Article. 10.1007/s00234-012-1115-8. 2013

Leptomeningeal gadolinium enhancement in multiple sclerosis

Gascon-Gimenez, F; (...); Casanova, V

Meeting Abstract. 2019

Leptomeningeal gadolinium enhancement lesions in multiple sclerosis are not related to different brain volume measures

Garcia, F; (...); Casanova, B

Meeting Abstract. 2018

Lipid-specific IgM oligoclonal bands in clinically isolated syndrome: 5-years follow-up

Molla, B.; (...); Casanova, B.

Meeting Abstract. 2014

Lipid-Specific Immunoglobulin M Bands in Cerebrospinal Fluid Are Associated with a Reduced Risk of Developing Progressive Multifocal Leukoencephalopathy during Treatment with Natalizumab

Villar LM; (...); Álvarez-Cermeño JC

Article. 10.1002/ana.24345. 2015

Lipid-specific oligoclonal IgM bands: is there any influence on the response to treatment with fingolimod?

Perez-Romero, L.; (...); Casanova, B.

Meeting Abstract. 2014

Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification.

Álvarez-Torres MDM; (...); Garcia-Gomez, Juan Miguel

Article. 10.1186/s12885-021-09117-4. 2022

Longitudinal studies of functional magnetic resonance imaging in first-episode psychosis: A systematic review

Gonzalez-Vivas, C; (...); Sanjuan, J

Review. 10.1016/j.eurpsy.2019.04.009. 2019

Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma.

Frasquet M; (...); Casanova B

Article. 10.1016/j.jneuroim.2013.07.003. 2013

Long-term efficacy of alemtuzumab in multiple sclerosis: a real word multicenter Spanish experience

Rubio Alcantud, Almudena; (...); Casanova, Bonaventura

Meeting Abstract. 2023

Long-term treatment effect over disability progression in patients with relapsing multiple sclerosis

Estruch, BC; (...); Coret, F

Meeting Abstract. 2017

Lung brain metastasis pseudoprogression after nivolumab and ipilimumab combination treatment

Melian, M; (...); Juan, O

Article. 10.1111/1759-7714.12873. 2018

Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarks.

Barreiro-González A; (...); Casanova B

Article. 10.1016/j.jns.2020.117180. 2020

MAINTENANCE TREATMENT WITH ADALIMUMAB IN REFRACTORY UVEITIS DUE TO BEHCET'S DISEASE: OPTIMISED VS NON-OPTIMISED GROUP

Martin-Varillas, JL; (...); Blanco, R

Meeting Abstract. 10.1136/annrheumdis-2018-eular.3963. 2018

Methotrexate as a treatment in ocular cicatricial moderate pemphigoid.

Hervás Ontiveros A; (...); Díaz-Llopis M

Article. 10.1016/j.oftal.2013.10.009. 2014

Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview

Garcia-Foncillas, J; (...); Gomez, MVP

Review. 10.1007/s40291-021-00544-4. 2021

miR-133a Enhances the Protective Capacity of Cardiac Progenitors Cells after Myocardial Infarction

Izarra A; (...); Bernad A

Article. 10.1016/j.stemcr.2014.10.010. 2014

miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.

Munoz-San Martin, Maria; (...); Ramio-Torrenta, Lluis

Article. 10.1212/NXI.0000000000200069. 2023

Mohs micrographic surgery in dermatofibrosarcoma protuberans: Rate and risk factors for recurrence in a prospective cohort study from the Spanish Registry of Mohs Surgery (REGESMOHS) and review of the literature.

Nieto-Benito LM; (...); Garcia-Doval I

Review. 10.1111/exd.14291. 2021

Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery).

Abril-Pérez C; (...); Botella-Estrada R

Article. 10.1111/jdv.20103. 2024

Multimodal Evaluation of Visual Function in Geographic Atrophy versus Normal Eyes

Burguera-Gimenez, N; (...); Jonna, G

Article. 10.2147/OPTH.S246245. 2020

Multi-parametric MR Imaging Biomarkers Associated to Clinical Outcomes in Gliomas: A Systematic Review.

Oltra-Sastre M; (...); Garcia-Gomez JM

Article. 10.2174/1573405615666190109100503. 2019

Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors

Haines JD; (...); Lopez-Rodas G

Article. 10.1177/1352458515573094. 2015

Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.

Article. 10.1016/j.ad.2023.08.001. 2023

Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.

Mansilla-Polo, M., Escutia-Munoz, B., Botella-Estrada, R.

Article. 10.1016/j.ad.2023.05.015. 2023

Neuromyelitis optica associated with the use of Atezolizumab in a patient with advanced lung adenocarcinoma.

Pedrero Prieto, Manuel; (...); Casanova Estruch, Bonaventura

Article. 10.1007/s10072-023-07252-3. 2023

Neuromyelitis optica spectrum disorders Comparison according to the phenotype and serostatus

Sepúlveda M; (...); Saiz A

Article. 10.1212/NXI.0000000000000225. 2016

New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab.

Toboso I; (...); Villar LM

Article. 10.3389/fneur.2020.579438. 2020

NFL during acute spinal cord lesions in MS: a hurdle for the detection of inflammatory activity.

Article. 10.1007/s00415-021-10926-7. 2022

NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases

Nadal, E.; (...); Bruna, J.

Meeting Abstract. 2022

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis.

Alcala Vicente, Carmen; (...); Casanova, Bonaventura

Article. 10.3389/fneur.2022.991596. 2022

Oligoclonal M bands distinguish two MS populations based on neurofilament light chain levels in patients without inflammatory activity

Castillo, J.; (...); Casanova, B.

Meeting Abstract. 2022

Oligoclonal M bands unveil occult inflammation in multiple sclerosis.

Casanova B; (...); Pérez-Miralles F

Article. 10.1016/j.msard.2022.104118. 2022

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies.

Coret F; (...); Casanova B

Article. 10.1177/2055217318783347. 2018

Optic nerve melanocytoma.

Gallego-Pinazo R; (...); Espana-Gregori E

Article. 10.1016/j.oftal.2016.05.014. 2016

Optical Coherence Tomography Characterization of Macular Changes Secondary to Arteriovenous Fistula

Pascual-Camps, I; (...); Espana-Gregori, E

Article. 10.1080/01658107.2017.1371768. 2018

Optimization Protocol for Adalimumab Treatment in Refractory Uveitis Due to Behcet's Disease

Martin-Varillas, JL; (...); Blanco, R

Meeting Abstract. 2018

Orbital involvement by non-Hodgkin lymphoma NK T cells.

Hervás-Ontiveros A; (...); Díaz-Llopis M

Article. 10.1016/j.oftal.2013.10.006. 2014

Papulonecrotic tuberculides as a key to the diagnosis of tuberculosis: a case report.

Letter. 10.1111/ijd.16940. 2024

pBrain: A novel pipeline for Parkinson related brain structure segmentation.

Manjón JV; (...); Coupe P

Article. 10.1016/j.nicl.2020.102184. 2020

Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder

Meca-Lallana, JE; (...); Maurino, J

Article. 10.2147/PPA.S305707. 2021

Perception of stigma in patients with primary progressive multiple sclerosis.

Pérez-Miralles F; (...); Casanova-Estruch B

Article. 10.1177/2055217319852717. 2019

Perception of stigma in people with neuromyelitis optica spectrum disorders (PERSPECTIVES-NMO Study)

Lallana, Jose Meca; (...); Maurino, Jorge

Meeting Abstract. 2021

Periorbital necrotising fasciitis secondary to scratching.

Placinta IA; (...); Bort-Martí MÁ

Article. 10.1016/j.oftal.2019.01.005. 2019

Peripapillary capillary network in dominant optic atrophy linked to OPA1 gene

Rahhal-Ortuno, Miriam; (...); Espana-Gregori, Enrique

Article. 10.1177/11206721211044846. 2021

Peripapillary retinal nerve fibre layer correlates better with spinal cord volume than with brain parenchymal fraction in multiple sclerosis

Barreiro-Gonzalez, A; (...); Casanova, B

Meeting Abstract. 2019

Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis.

Mathur D; (...); Marti MB

Article. 10.3389/fneur.2014.00250. 2014

Podocalyxin-like protein 1 is a relevant marker for human c-kit(pos) cardiac stem cells

Moscoso I; (...); Bernad A

Article. 10.1002/term.1795. 2016

Posterior Capsular Opacification and Glistening in Hydrophobic Monofocal Biaspheric Intraocular Lens Two Years After Implantation: A Case Control Study

Hervas-Ontiveros, Ana; (...); Cervino, Alejandro

Article. 10.1155/joph/3520219. 2024

Posterior scleral perforation due to endogenous endophthalmitis in a pregnant with selective IgA deficiency.

Aguilar-González M; (...); Espana-Gregori, Enrique

Article. 10.22336/rjo.2022.19. 2022

Post-treatment changes of tumour perfusion parameters can help to predict survival in patients with high-grade astrocytoma

Sanz-Requena, R; (...); Marti-Bonmati, L

Article. 10.1007/s00330-016-4699-2. 2017

Potential Biomarkers Associated with Multiple Sclerosis Pathology.

Mathur, Deepali; (...); Casanova, Bonaventura

Article. 10.3390/ijms221910323. 2021

Potential Role of CHI3L1+ Astrocytes in Progression in MS.

Cubas-Núñez L; (...); Casanova B

Article. 10.1212/NXI.0000000000000972. 2021

Pourfour du Petit syndrome associated with a cervical vertebral anomaly.

Marín-Lambíes C; (...); Díaz-Llopis M

Article. 10.1097/WNO.0b013e3182625212. 2012

Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients.

Tortosa-Carreres J; (...); Pérez-Miralles FC

Article. 10.1016/j.msard.2024.105734. 2024

Predictive value of early brain atrophy on response in patients treated with interferon ß.

Pérez-Miralles FC; (...); Montalban X

Article. 10.1212/NXI.0000000000000132. 2015

Predictive value of isolated CSF NfL and Chi3l1 measures in clinical practice

Gil-Perotin, S; (...); Casanova-Estruch, B

Meeting Abstract. 2018

Preliminarily results of the Oncohabitats Study: A multicentre validation of overall survival (OS) estimation of patients with glioblastoma (GBM) using vascular biomarkers

Alvarez-Torres, MD; (...); Garcia-Gomez, JM

Meeting Abstract. 10.1158/1538-7445.AM2019-4258. 2019

Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report

Gil-Perotin, S; (...); Casanova-Estruch, B

Article. 10.3389/fneur.2018.00340. 2018

Proptosis as initial manifestation of Burkitt's lymphoma with orbital involvement.

de Freytas A, Rengel Ruiz M, Espana Gregori E

Article. 10.1016/j.oftal.2016.10.002. 2017

Prospective Study: Utility of Anterior Segment Optical Coherence Tomography to Identify Predictive Factors of Recurrence in Pterygium Surgery.

Aguilar-Gonzalez, Marina; (...); Peris-Martinez, Cristina

Article. 10.3390/jcm13164769. 2024

Pseudogranulomatous Spitz nevus: a variant of Spitz nevus with heavy inflammatory infiltrate mimicking a granulomatous dermatitis.

Sabater Marco V; (...); Botella Estrada R

Article. 10.1111/cup.12011. 2013

Purtscher-like retinopathy following carotid angioplasty and stenting in the treatment of severe carotid stenosis.

Solaz-Ruiz, M G; (...); Espana-Gregori, E

Article. 10.1177/11206721231204632. 2023

Quantifying the patient ' s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire

Meca-Lallana, JE; (...); Ballesteros, J

Article. 10.1371/journal.pone.0255317. 2021

Quantifying the patient's perspective in neuromyelitis optica spectrum disorders: design of a multicenter, non-interventional study

Meca-Lallana, J; (...); Maurino, J

Meeting Abstract. 2020

Quantitative structural analysis of trabecular alveolar bone in the mandible by multidetector computed tomography: differences according to tooth presence and type

Sanz-Requena, R; (...); Marti-Bonmati, L

Article. 10.1016/j.rx.2019.01.003. 2019

Rabdomiosarcoma alveolar orbitario enmascarado por sinusitis etmoidal en un adulto de 25 anos.

Sanz-Marco E; (...); Díaz-Llopis M

Abstract of Published Item. 10.1016/j.oftal.2012.10.012. 2014

Rapid Improvement with Tocilizumab in Refractory and Severe Uveitic Cystoid Macular Edema

Vegas-Revenga, N; (...); Blanco, R

Meeting Abstract. 2017

Rapid-onset voriconazole-induced cicatricial ectropion.

Pérez-López M; (...); Espana-Gregori, E

Article. 10.1016/j.jfo.2021.06.029. 2022

Reactive arthritis.

Article. 10.1016/j.medcli.2023.08.017. 2023

Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1111/ajd.14339. 2024

Recalcitrant lichen planopilaris treated with upadacitinib: a case series

Lasheras-Perez, Miguel A.; (...); Botella-Estrada, Rafael

Article. 10.1111/ijd.17339. 2024

Recambio plasmático terapéutico: aplicaciones en neurología.

Láinez-Andrés JM; (...); Santonja JM

Abstract of Published Item. 10.33588/rn.6003.2014393. 2015

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses.

Ramo-Tello, Cristina; (...); Rovira À

Article. 10.3390/jpm12010006. 2021

Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease

Alcala, C; (...); Casanova, B

Editorial Material. 10.1016/j.msard.2018.12.005. 2019

Refractory and Severe Uveitic Cystoid Macular Edema Improves with Tocilizumab in Different Immune Mediated Diseases

Vegas-Revenga, N; (...); Blanco, R

Meeting Abstract. 2018

Relapsing inflammatory optic neuropathy: clinical description in a serie of 16 patients

Navarro, L.; (...); Casanova, B.

Meeting Abstract. 2014

Relationship among Corneal Biomechanics, Refractive Error, and Axial Length

Bueno-Gimeno I; (...); Pinero-Llorens DP

Article. 10.1097/OPX.0000000000000231. 2014

Relationship between different cerebrospinal fluid biomarkers in multiple sclerosis: meaning and use in clinical practice

Castillo, J; (...); Casanova, B

Meeting Abstract. 2017

Renal function influences serum neurofilament light chain levels in patients with multiple sclerosis

Gasque Rubio, R.; (...); Casanova Estruch, B.

Meeting Abstract. 2022

Renal function's impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysis.

Tortosa-Carreres, Jordi; (...); Perez-Miralles, Francisco

Article. 10.1007/s10072-024-07772-6. 2024

Retrospective research of cutaneous and mucosal leishmaniasis in a Spanish hospital of an endemic zone of Leishmania donovani infantum infection

Sahuquillo, Antonio; (...); Botella, Rafael

Meeting Abstract. 2017

Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)

Fernandez, Oscar; (...); Tintore, Mar

Article. 10.33588/rn.6105.2015228. 2015

Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II)

Fernandez O; (...); Grupo Post-Ectrims GP

Article. 10.33588/rn.6106.2015239. 2015

Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (I)

Fernandez, O; (...); Rodriguez-Antiguedad, A

Review. 10.33588/rn.6501.2017168. 2017

Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (II)

Fernandez, Oscar; (...); Rodriguez-Antiguedad, Alfredo

Review. 10.33588/rn.6502.2017169. 2017

Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).

Fernández Ó; (...); Grupo Post-ECTRIMS

Article. 10.33588/rn.5705.2013270. 2013

Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).

Fernandez O; (...); Grupo Post-Ectrims GP

Article. 10.33588/rn.5706.2013276. 2013

Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).

Fernández Ó; (...); Post-ECTRIMS Group

Article. 10.33588/rn.5707.2013277. 2013

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)

Fernandez O; (...); Grupo Post-Ectrims GP

Article. 10.33588/rn.5906.2014321. 2014

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)

Fernandez, Oscar; (...); Rodriguez-Antigueedad, Alfredo

Article. 10.33588/rn.5907.2014334. 2014

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III)

Fernández Ó; (...); Grupo Post-ECTRIMS

Article. 10.33588/rn.5908.2014335. 2014

Revision de las novedades del congreso conjunto ECTRIMS-ACTRIMS 2014, presentadas en la VII Reunion Post-ECTRIMS (I).

Fernandez O; (...); Grupo Post-Ectrims GP

Abstract of Published Item. 10.33588/rn.6105.2015228. 2015

Revision de las novedades del XXXII Congreso ECTRIMS 2016, presentadas en la IX Reunion Post-ECTRIMS (II).

Fernandez O; (...); Rodriguez-Antiguedad A

Article. 10.33588/rn.6502.2017169. 2017

Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery)

Tomas-Velazquez, Alejandra; (...); Redondo, Pedro

Article. 10.2340/actadv.v101.544. 2021

Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer -Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.

Miñano Medrano R; (...); García-Doval I

Article. 10.1016/j.ad.2022.01.003. 2022

Risk of transition to secondary progressive multiple sclerosis and accumulation of disability in progressive multiple sclerosis are not influenced by current therapies

Alcala, C; (...); Casanova, B

Meeting Abstract. 2017

Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study.

Álvarez-Torres MDM; (...); García-Gómez JM

Article. 10.1002/jmri.26958. 2020

Role of the Dermatologist in the Care of Hospitalized Transplant Patients

Escutia Muñoz B

Editorial Material. 10.1016/j.ad.2018.11.001. 2018

Safety profile and practical considerations of monoclonal antibody treatment.

Casanova Estruch B

Article. 10.1016/j.nrl.2011.02.004. 2013

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.

Arrambide, Georgina; (...); Meca-Lallana, Jose E

Article. 10.1212/NXI.0000000000001024. 2021

Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.

Fissolo, Nicolas; (...); Comabella, Manuel

Article. 10.1136/jnnp-2023-332251. 2023

Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.

Monreal E; (...); Villar LM

Article. 10.1093/brain/awae260. 2024

Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels at Disease Onset for Prediction of the Risk of Disability Worsening in Patients with Multiple Sclerosis

Monreal, Enric; (...); Villar Guimerans, Luisa Maria

Meeting Abstract. 2023

Serum neurofilament light chain and glial fibrillary acidic protein levels at disease onset unveil immunological pathways of disability acquisition in multiple sclerosis

Monreal, Enric; (...); Villar Guimerans, Luisa Maria

Meeting Abstract. 2024

Serum Neurofilament Light Chain is a surrogate marker of NEDA-3 in Multiple Sclerosis

Gascon Gimenez, Francisco Guillermo; (...); Casanova, Bonaventura

Meeting Abstract. 2023

SfM-3DULC: Reliability of a new 3D wound measurement procedure and its accuracy in projected area.

Sánchez-Jiménez D; (...); Botella-Estrada R

Article. 10.1111/iwj.13595. 2021

Short- and long-term outcomes in non-aneurysmal non-perimesencephalic subarachnoid hemorrhage

Lago A; (...); Parkhutik V

Article. 10.1080/01616412.2016.1200306. 2016

Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study).

Pérez-Miralles F; (...); Casanova B

Article. 10.1016/j.msard.2021.102860. 2021

Silent Progression or Bout Onset Progressive Multiple Sclerosis?

Gil-Perotin, S; (...); Casanova, B

Letter. 10.1002/ana.25537. 2019

Single Digital Metastasis of Rectal Adenocarcinoma

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Letter. 10.1097/DAD.0000000000002529. 2023

Skin lesions in a lung transplant recipient

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Editorial Material. 10.1016/j.eimc.2023.09.005. 2024

Skin lesions in a lung transplant recipient.

Botella Estrada R, Escutia Muñoz B

Case Reports. 10.1016/j.eimce.2023.09.005. 2024

Slow-growing scaly erythematous plaque on the face and scalp of an elderly woman.

Torres Garcia Y, Escutia Muñoz B, Botella Estrada R

Article. 10.1016/j.adengl.2013.02.009. 2013

Somatic hypermutation of intrathecal IgM-producing B cells in multiple sclerosis patients

Beltran, Eduardo; (...); Casanova, Bonaventura

Article. 2012

Spanish registry of multiple sclerosis patients on glatiramer acetate 40 mg/ml treatment: Real-world results and baseline characteristics of initial patients

Fernandez, O; (...); Sanchez-de la Rosa, R

Meeting Abstract. 2017

Spanish Registry of patients with multiple sclerosis treated with fingolimod (GILENYA Registry): safety and effectiveness after one year on treatment

Rodriguez-Antigueedad, A.; (...); Fernandez, O.

Article. 2014

Spinal cord atrophy but not brain atrophy measures, correlates with the Multiple Sclerosis Severity Score

Carratala, S; (...); Estruch, BC

Meeting Abstract. 2018

Staging and follow-up of patients with melanoma: which tests for which patients?

Article. 10.1016/j.ad.2013.11.002. 2014

State of the art of Mohs surgery for rare cutaneous tumors in the Spanish Registry of Mohs Surgery (REGESMOHS).

Rodríguez-Jiménez P; (...); Descalzo MA

Article. 10.1111/ijd.14732. 2020

Straatsma Syndrome and cataract: case report and review of the literature.

Blanca, Casado-Pelaez; (...); Enrique, Espana-Gregori

Review. 10.22336/rjo.2023.67. 2023

Stroke and temporal arteritis: A study of 6 cases.

Lago A; (...); Aparici F

Article. 10.1016/j.nrl.2017.06.003. 2020

STUDY OF THE EFFECTIVENESS OF IMATINIB IN CHRONIC GRAFT-VERSUS-HOST DISEASE IN A SERIES OF 19 CASES

Poveda, PM; (...); Caballer, JS

Meeting Abstract. 2017

Successful systemic fibrinolysis in a patient with bacterial endocarditis

Gorriz, D; (...); Lago, A

Letter. 10.33588/rn.6209.2015331. 2016

Successful Treatment of Stimulator of Interferon Genes-Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab.

Article. 10.1001/jamadermatol.2024.2160. 2024

Sustained hyperammonemia induces TNF-a IN Purkinje neurons by activating the TNFR1-NF-?B pathway.

Balzano T; (...); Felipo V

Article. 10.1186/s12974-020-01746-z. 2020

Symptom severity in Neuromyelitis Optica Spectrum Disorder from the patients' perspective

Meca-Lallana, J.; (...); Maurino, J.

Meeting Abstract. 2021

Symptomatic accommodative and binocular dysfunctions from the use of flat-panel displays

Porcar, E; (...); Espana-Gregori, E

Article. 10.18240/ijo.2018.03.22. 2018

Temporal artery biopsy.

Suelves AM, España Gregori E, Díaz-Llopis M

Letter. 10.1016/j.ophtha.2013.08.023. 2013

Tendencies in cerebral aneurism treatment: Analysis of a hospital series

Lago, A; (...); Parkhutik, V

Article. 10.1016/j.nrl.2015.12.011. 2017

Tendencies in cerebral aneurism treatment: Analysis of a hospital series (vol 32, pg 371, 2017)

Lago, A; (...); Parkhutik, V

Correction. 10.1016/j.nrl.2017.07.003. 2017

The contribution of brain volume to explain autonomous imbalance during recovery from acute stress in batterers.

Romero-Martinez, Angel; (...); Moya-Albiol, Luis

Letter. 10.1007/s00429-024-02772-w. 2024

The effect of intravenous immunoglobulin on neuromyelitis optica.

Magraner MJ, Coret F, Casanova B

Article. 10.1016/j.nrl.2012.03.014. 2013

The impact of stigma in people with primary progressive multiple sclerosis

Perez-Miralles, F; (...); Casanova-Estruch, B

Meeting Abstract. 2018

The role of intimate partner violence perpetrators' resting state functional connectivity in treatment compliance and recidivism.

Romero-Martinez, Angel; (...); Moya-Albiol, Luis

Article. 10.1038/s41598-024-52443-3. 2024

The use of the vessel loop to bolster mattress sutures and prevent scars

MOLES, P.; (...); Botella-Estrada R

Editorial Material. 10.1016/j.jaad.2017.10.031. 2018

Therapeutic plasma exchange: applications in neurology

Lainez-Andres, Jose M.; (...); Santonja, Jose M.

Article. 10.33588/rn.6003.2014393. 2015

Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.

Pascual-Camps I; (...); Espana-Gregori E

Article. 10.1080/01676830.2018.1435694. 2018

Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel

de Unamuno Bustos B; (...); Botella Estrada R

Article. 10.1038/s41598-017-00606-w. 2017

Toxicity to intravitreal melphalan in a patient with retinoblastoma.

Solaz-Ruiz, Marta Gema; (...); Espana-Gregori, Enrique

Case Reports. 10.22336/rjo.2023.49. 2023

Treatment of multiple sclerosis with Rituximab: a multicenter Spanish experience